Literature DB >> 2991233

Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase.

R L Kincaid, I E Stith-Coleman, M Vaughan.   

Abstract

Purified calmodulin-stimulated cyclic nucleotide phosphodiesterase from brain, a homodimer of 59-kDa subunits, was activated by limited proteolysis with trypsin, alpha-chymotrypsin, Pronase, or papain and could not be further stimulated by addition of Ca2+ and calmodulin. Proteolysis increased Vmax and had little effect on the Km for cGMP. Treatment with alpha-chymotrypsin in the presence of ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) produced, sequentially, 57- and 45-kDa peptides from the bovine and 55-, 53-, and 38-kDa peptides from the ovine enzyme. This protease-treated phosphodiesterase exhibited a Stokes radius of 3.9 nm and an S20,w value of 4.55; comparison with the hydrodynamic properties observed for native enzyme (4.3 nm, 5.95 S) strongly suggests a dimeric protein of Mr approximately 80,000-90,000. The proteolyzed species does not interact significantly with calmodulin immobilized on agarose, nor does it show complex formation with 2-dimethylaminonaphthalene-1-sulfonyl-calmodulin even at micromolar concentrations of protein. Proteolysis, in the presence of calmodulin plus Ca2+, fully activated phosphodiesterase, producing the same intermediate peptides; however, final peptides from the bovine and ovine enzymes were 47 and 42 kDa, respectively, indicating a new, specific conformation of the enzyme. When EGTA was added to such incubations, these peptides were cleaved to those of the size seen when proteolysis was carried out entirely in the presence of EGTA. The initial rate of activation was increased by the presence of Ca2+ and calmodulin, suggesting that, in complex, phosphodiesterase exhibits a site with increased susceptibility to proteolysis. Since calmodulin can still interact with a fully activated form of the enzyme, it appears that retention of calmodulin binding can occur concomitantly with damage to that portion of the phosphodiesterase molecule responsible for suppression of its basal catalytic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991233

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  The influence of extracellular and intracellular calcium on the secretion of renin.

Authors:  Douglas K Atchison; William H Beierwaltes
Journal:  Pflugers Arch       Date:  2012-04-28       Impact factor: 3.657

Review 2.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

3.  Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.

Authors:  C Schudt; S Winder; S Forderkunz; A Hatzelmann; V Ullrich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

Review 4.  Histochemistry of nucleotidyl cyclases and cyclic nucleotide phosphodiesterases.

Authors:  G Poeggel; H Luppa
Journal:  Histochem J       Date:  1988-05

Review 5.  cAMP and Ca²⁺ signaling in secretory epithelia: crosstalk and synergism.

Authors:  Malini Ahuja; Archana Jha; Jozsef Maléth; Seonghee Park; Shmuel Muallem
Journal:  Cell Calcium       Date:  2014-02-07       Impact factor: 6.817

6.  KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.

Authors:  M Ichimura; R Eiki; K Osawa; S Nakanishi; H Kase
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

7.  Use of a yeast expression system for the isolation and analysis of drug-resistant mutants of a mammalian phosphodiesterase.

Authors:  R Pillai; K Kytle; A Reyes; J Colicelli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

Review 8.  The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases.

Authors:  J Beltman; W K Sonnenburg; J A Beavo
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

9.  Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase.

Authors:  E Meacci; M Taira; M Moos; C J Smith; M A Movsesian; E Degerman; P Belfrage; V Manganiello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Analysis of substrate specificity and kinetics of cyclic nucleotide phosphodiesterases with N'-methylanthraniloyl-substituted purine and pyrimidine 3',5'-cyclic nucleotides by fluorescence spectrometry.

Authors:  Daniel Reinecke; Frank Schwede; Hans-Gottfried Genieser; Roland Seifert
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.